Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired (Tables)

v3.3.0.814
Licenses Acquired (Tables)
 9 Months Ended
Sep. 30, 2015
Research and Development [Abstract]  
Research and Development Arrangement, Contract to Perform for Others
For the three months and nine months ended September 30, 2015, the Company’s research and development-licenses  are comprised of the following:
 
 
 
For the Three
 
For the Nine
 
 
 
Months Ended
 
Months Ended
 
($ in thousands)
 
September 30, 2015
 
September 30, 2015
 
Fortress:
 
 
 
 
 
 
 
IV Tramadol (1)
 
$
-
 
$
3,000
 
 
 
 
 
 
 
 
 
Fortress Companies:
 
 
 
 
 
 
 
Mustang
 
 
-
 
 
2,147
 
Checkpoint
 
 
600
 
 
2,633
 
Coronado SO
 
 
-
 
 
1,607
 
Helocyte
 
 
-
 
 
200
 
Escala
 
 
1,295
 
 
1,295
 
Total
 
$
1,895
 
$
10,882
 
 
(1)    Fortress intends to transfer IV Tramadol to Avenue.